| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/FEBS.12264 |
| P8608 | Fatcat ID | release_zvymvwvawbemfebexxemnpahbi |
| P932 | PMC publication ID | 3806276 |
| P698 | PubMed publication ID | 23551903 |
| P5875 | ResearchGate publication ID | 236102925 |
| P50 | author | Aleksander Koj | Q4714948 |
| Jolanta Jura | Q59696009 | ||
| Łukasz Skalniak | Q60594412 | ||
| P2860 | cites work | Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8. | Q40273993 |
| Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. | Q40597958 | ||
| Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signal-regulating kinase-dependent extracellular signal-related kinase and c-Jun N-terminal kinase activation | Q40714039 | ||
| Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. | Q41017734 | ||
| Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. | Q43241254 | ||
| Proteasome inhibitor MG-132 enhances the expression of interleukin-6 in human umbilical vein endothelial cells: Involvement of MAP/ERK kinase | Q44029920 | ||
| The proteasome inhibitor PS-341 in cancer therapy. | Q54077971 | ||
| NF-κB p105 Processing via the Ubiquitin-Proteasome Pathway | Q57024845 | ||
| Differential IκB Kinase Activation and IκBα Degradation by Interleukin-1β and Tumor Necrosis Factor-α in Human U937 Monocytic Cells | Q58450597 | ||
| Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine | Q71586820 | ||
| Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators | Q77845928 | ||
| The potential of proteasome inhibitors in cancer therapy | Q94700475 | ||
| NIH Image to ImageJ: 25 years of image analysis | Q23319322 | ||
| The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1 | Q24294979 | ||
| A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages | Q24305522 | ||
| Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions | Q26823168 | ||
| Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction | Q28116119 | ||
| MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation | Q28117210 | ||
| Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1beta mRNA | Q28118792 | ||
| MCP-1-induced protein attenuates endotoxin-induced myocardial dysfunction by suppressing cardiac NF-кB activation via inhibition of IкB kinase activation | Q28504691 | ||
| MCP-1 (monocyte chemotactic protein-1)-induced protein, a recently identified zinc finger protein, induces adipogenesis in 3T3-L1 pre-adipocytes without peroxisome proliferator-activated receptor gamma | Q28506501 | ||
| Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay | Q28588318 | ||
| MCPIP1 down-regulates IL-2 expression through an ARE-independent pathway | Q28588817 | ||
| Monocyte chemotactic protein-induced protein 1 (MCPIP1) suppresses stress granule formation and determines apoptosis under stress | Q28589906 | ||
| Towards a knowledge-based Human Protein Atlas | Q29617987 | ||
| Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation | Q33358022 | ||
| Transcription factors Elk-1 and SRF are engaged in IL1-dependent regulation of ZC3H12A expression | Q33529882 | ||
| Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation | Q33855223 | ||
| Taking a bite: proteasomal protein processing | Q33958918 | ||
| Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP. | Q34062711 | ||
| Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding protein | Q34148151 | ||
| p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts | Q34811464 | ||
| Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy | Q35602113 | ||
| Regulation of gene expression by the ubiquitin-proteasome system | Q36098850 | ||
| Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma | Q36384889 | ||
| Proteasome inhibitor induces apoptosis through induction of endoplasmic reticulum stress. | Q36544379 | ||
| Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells | Q36572406 | ||
| Proteasome inhibition: a new therapeutic strategy to cancer treatment | Q37687583 | ||
| Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy | Q37913447 | ||
| Proteasome inhibitors in multiple myeloma: 10 years later | Q38014395 | ||
| New proteasome inhibitors in myeloma | Q38052079 | ||
| MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP. | Q39772786 | ||
| Regulatory feedback loop between NF-kappaB and MCP-1-induced protein 1 RNase | Q39800740 | ||
| MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling | Q39888649 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2665-2674 | |
| P577 | publication date | 2013-05-07 | |
| P1433 | published in | FEBS Journal | Q1388041 |
| P1476 | title | Proteasome inhibitor MG-132 induces MCPIP1 expression | |
| P478 | volume | 280 |
| Q89700569 | Central role of myeloid MCPIP1 in protecting against LPS-induced inflammation and lung injury |
| Q36289344 | MCPIP1 Regulates Fibroblast Migration in 3-D Collagen Matrices Downstream of MAP Kinases and NF-κB |
| Q36693265 | MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression |
| Q41022521 | MCPIP1 contributes to clear cell renal cell carcinomas development |
| Q34038263 | MCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κB |
| Q52877401 | MG132 Induces Expression of Monocyte Chemotactic Protein-Induced Protein 1 in Vascular Smooth Muscle Cells. |
| Q38840679 | Monocyte Chemoattractant Protein-Induced Protein 1 Overexpression Modulates Transcriptome, Including MicroRNA, in Human Neuroblastoma Cells. |
| Q39042850 | RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins |
| Q33652118 | Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses |
Search more.